Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
pf-07329640
Melanoma
Pfizer
P1
C
(37)
pf-07799544
Melanoma
Pfizer
P1
C
(37)
pf-07820435
Melanoma
Pfizer
P1
C
(37)
pf-07820435
Neoplasm
Pfizer
P1
C
(37)
pf-07820435
Renal Cell Carcinoma
Pfizer
P1
C
(37)
pf-07826390
Neoplasm
Pfizer
P1
C
(37)
pf-07826390
Renal Cell Carcinoma
Pfizer
P1
C
(37)
pf-07921585
Melanoma
Pfizer
P1
C
(37)
pf-07921585
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
pf-07921585
Renal Cell Carcinoma
Pfizer
P1
C
(37)
pf-07934040
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
pf-07985045
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
pf-08032562
Triple-Negative Breast Carcinoma
Pfizer
P1
C
(37)
pf-08046031
Neoplasm
Pfizer
P1
C
(37)
pf-08046032
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
C
(37)
pf-08046032
Melanoma
Pfizer
P1
C
(37)
pf-08046033
Esophageal Cancer
Pfizer
P1
C
(37)
pf-08046876
Esophageal Cancer
Pfizer
P1
C
(37)
Claturafenib
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(36)
Maplirpacept
Lymphoma
Pfizer
P1
C
(36)
pf-07224826
Breast Cancer
Pfizer
P1
C
(36)
pf-07224826
Ovarian Cancer
Pfizer
P1
C
(36)
pf-07263689
Colorectal Cancer
Pfizer
P1
C
(36)
pf-07263689
Ovarian Cancer
Pfizer
P1
C
(36)
pf-07265028
Cancer
Pfizer
P1
C
(36)
Showing 401 to 425 of 461 assets
Previous
Page 17 of 19
Next
